Chu Chieh Hsia

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi request reprint Quantification of hepatitis B virus genomes and infectivity in human serum samples
    Chu Chieh Hsia
    Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Bethesda, Maryland, USA
    Transfusion 46:1829-35. 2006
  2. ncbi request reprint Microarray multiplex assay for the simultaneous detection and discrimination of hepatitis B, hepatitis C, and human immunodeficiency type-1 viruses in human blood samples
    Chu Chieh Hsia
    Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Review, Food and Drug Administration, Bethesda, MD 20892, USA
    Biochem Biophys Res Commun 356:1017-23. 2007
  3. ncbi request reprint Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection
    Robin Biswas
    Food and Drug Administration, Center for Biologics Evaluation and Research, Rockville, Maryland, USA
    Transfusion 43:788-98. 2003
  4. ncbi request reprint Truncated hepatitis C virus core protein encoded in hepatocellular carcinomas
    Rin Yamaguchi
    Division of Emerging and Transfusion Transmitted Diseases, Food and Drug Administration, Bethesda, MD 20852, USA
    Int J Mol Med 14:1097-100. 2004

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Quantification of hepatitis B virus genomes and infectivity in human serum samples
    Chu Chieh Hsia
    Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Bethesda, Maryland, USA
    Transfusion 46:1829-35. 2006
    ....
  2. ncbi request reprint Microarray multiplex assay for the simultaneous detection and discrimination of hepatitis B, hepatitis C, and human immunodeficiency type-1 viruses in human blood samples
    Chu Chieh Hsia
    Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Review, Food and Drug Administration, Bethesda, MD 20892, USA
    Biochem Biophys Res Commun 356:1017-23. 2007
    ..Our data represent a proof-of-concept for the possible use of highly sensitive multiplex microarray assay to screen and confirm the presence of these viruses in blood donors and patients...
  3. ncbi request reprint Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection
    Robin Biswas
    Food and Drug Administration, Center for Biologics Evaluation and Research, Rockville, Maryland, USA
    Transfusion 43:788-98. 2003
    ..A study was designed to estimate relative analytic sensitivity and window-period (WP) closure and to project incremental yield of newer HBsAg tests, pooled-sample NAT, and single-sample NAT, compared to currently licensed HBsAg tests...
  4. ncbi request reprint Truncated hepatitis C virus core protein encoded in hepatocellular carcinomas
    Rin Yamaguchi
    Division of Emerging and Transfusion Transmitted Diseases, Food and Drug Administration, Bethesda, MD 20852, USA
    Int J Mol Med 14:1097-100. 2004
    ....